CTOs on the Move

Helicor

www.helicor.com

 
Helicor, Inc. is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.helicor.com
  • 156 5th Ave Ste 1218
    New York, NY USA 10010
  • Phone: 212.346.9339

Executives

Name Title Contact Details

Similar Companies

Metamason

Metamason is dedicated to improving healthcare through technological innovation. Our health-focused software platform uses 3D scans of the body to create individually customized, 3D-printed products engineered for flawless fit.

Medbox Inc

Medbox, Inc. develops, sells, and services automated, biometrically controlled dispensing and storage systems for medicine and merchandise applications. Its products comprise Medbox medicine storage machines; safe access storage lockers; Medbox lockbox Rx storage/retrieval systems; Medbox OTC machines; and Medbox Sample-Safe, a wall-mounted unit for use in doctor’s offices. Medbox, Inc. provides its patented systems, software, and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities and medical groups worldwide. The company was formerly known as MindfulEye, Inc. and changed its name to Medbox, Inc. in August 2011. Medbox, Inc. is headquartered in West Hollywood, California.

Telemed Systems Inc

Telemed Systems Inc is a Hudson, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avedro

Avedro is a privately held pharmaceutical and medical device company advancing the science and technology of corneal cross-linking and refractive correction.

RenalGuard Solutions

Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.